<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="66972">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01692639</url>
  </required_header>
  <id_info>
    <org_study_id>5313</org_study_id>
    <nct_id>NCT01692639</nct_id>
  </id_info>
  <brief_title>Acute Acetaminophen Ingestion: Does Repeated Acetaminophen Blood Test Have an Interest?</brief_title>
  <official_title>Acute Acetaminophen Ingestion: Does Repeated Acetaminophen Blood Test Have an Interest?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <authority>France:France: Institutional Ethical Committee.</authority>
    <authority>France: The Commission nationale de l’informatique et des libertés</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acetaminophen is the first drug involved in voluntary drug poisoning. According to the
      studies conducted in the USA and in the United Kingdom, it is the first cause of acute liver
      failure, and this poisoning is responsible of 10 percent of liver transplants each year in
      these countries. Mortality is about 1/3 at the stage of acute liver failure. The main risk
      factors are malnutrition and chronic alcoholism. Ease of access to this toxic and highly
      correlated with factors predisposing socio-economic field are an important issue, including
      the speed and appropriateness of care are key factors both in terms of reducing morbidity
      mortality in socio-economic terms for the community.A nomogram defines a statistical
      threshold from which the blood concentration of paracetamol has a significant risk of liver
      toxicity. The blood paracetamol dosage practiced today at the 4th hour after ingestion of a
      toxic dose, but there is no consensus on whether or not to repeat this dosage during the
      treatment, as the first result is beyond the threshold or not.The administration of the
      antidote NAC (N-acetyl-cysteine) in proven cases of liver toxicity is also regulated by a
      protocol that can vary in different services.In the absence of clear guidelines, the
      question of the need for iterative dosages of paracetamol blood beyond the fourth hour
      post-ingestion if the initial paracetamol blood measurement is below the curve nomogram
      remains open.Is it possible to limit blood tests to a single assay paracétamolémie to H4
      when it is below the curve, and thus enable the return home of the patient's somatic point
      of view (excluding psychiatric care when is voluntary drug intoxication), with consequences
      in terms of costs (hospital days) and duration of treatment?
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">May 2014</completion_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Acetaminophen Overdose</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients over 18 years with acute paracetamol ingestion admitted in a group of 8 emergency
        departments of the region Alsace, France (Strasbourg Hautepierre and Nouvel Hôpital Civil,
        Haguenau, Saverne,Wissembourg, Colmar, Sélestat, Mulhouse) and with a single dose of
        paracetamol over 4 grams.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients over 18 years

          -  Having taken a single dose of acetaminophen

          -  With a supposed ingested dose over 4 grams

        Exclusion Criteria:

          -  Patients treated with N-Acetyl

          -  Cysteine before their admissions in the participating units

          -  With repeted ingested doses

          -  Pregnant and nursing wifes

          -  Patients unable to give their consent to the study
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pascal BILBAULT, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpitaux Universitaires de Strasbourg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pascal BILBAULT, MD</last_name>
    <phone>33.3.88.12.82.21</phone>
    <email>pascal.bilbault@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pierre PERESSON</last_name>
    <phone>33.3.06.78.82.47.22</phone>
    <email>pierre.peresson@orange.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Hospitalier Gérontologique</name>
      <address>
        <city>Bischwiller</city>
        <zip>67241</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christophe BERNA, MD</last_name>
      <phone>33.3.06.32.65.31.87</phone>
      <email>Christophe.berna@free.fr</email>
    </contact>
    <investigator>
      <last_name>Christophe BERNA, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service d'accueil des Urgences, Hôpitaux Civils de Colmar, Centre Hospitalier Louis Pasteur</name>
      <address>
        <city>Colmar</city>
        <zip>68024</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric THIBAUD, MD</last_name>
      <phone>33.3.89.12.41.80</phone>
      <email>ethibaud@yahoo.fr</email>
    </contact>
    <investigator>
      <last_name>Eric THIBAUD, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>GERSTL-HINSCHBERGER Laure, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>KEMPF Nicolas, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>GETE Etienne, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>SAVINEAU-RAETH Jean-Remy, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>DUSSAU Leslie, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>ZINK Jean-Christophe, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>PATARIN Christelle, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Jacques OTT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service d'Accueil des Urgences, Centre Hospitalier de Haguenau</name>
      <address>
        <city>Haguenau</city>
        <zip>67500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Corina DUJA, MD</last_name>
      <phone>33.3..88.06.33.55</phone>
      <email>corina-mihaela.duja@ch-haguenau.fr</email>
    </contact>
    <investigator>
      <last_name>Corina DUJA, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service des Urgences, CH Emile Muller</name>
      <address>
        <city>Mulhouse</city>
        <zip>68051</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loïc LAVAILL, MD</last_name>
      <phone>33.3.89.64.66.09</phone>
      <email>kacems@ch-mulhouse.fr</email>
    </contact>
    <investigator>
      <last_name>Loïc LAVAILL, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service des Urgences, Centre Hospitalier de Sélestat</name>
      <address>
        <city>Selestat</city>
        <zip>67606</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas WEISS, MD</last_name>
      <phone>33.3.06.72.77.59.91</phone>
      <email>thomas.weiss@ch-selestat.fr</email>
    </contact>
    <investigator>
      <last_name>Thomas WEISS, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de Réanimation Médicale, Nouvel Hôpital Civil</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michel HASSELMANN, MD</last_name>
      <phone>33.3.69.55.11.23</phone>
      <email>michel.hasselmann@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Michel HASSELMANN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>DELABRANCHE Xavier, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>BERGER Asaël, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>KUMMERLEN Christine, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>NEAGU Anca Raluca, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>SCHNELL David, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service d'Accueil des Urgences, Nouvel Hôpital Civil</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric BAYLE, MD</last_name>
      <phone>33.3.69.55.10.45</phone>
      <email>eric.bayle@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Eric BAYLE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de Réanimation Médicale, Hôpital de Hautepierre</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francis SCHNEIDER, MD</last_name>
      <phone>33.3.88.12.79.22</phone>
      <email>francis.schneider@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Francis SCHNEIDER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Etienne HERBRECHT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>CASTELAIN Vincent, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>SCHENCK Maleka, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>JANSSEN-LANGENSTEIN Ralf, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>GUILLOT Max, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>HARLAY Marie-Line, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>DIOUF Mamadou Mansour, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>LUTUN Philippe, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service des Urgences, Hôpital de Hautepierre</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pascal BILBAULT, MD</last_name>
      <phone>33.3.88.12.82.21</phone>
      <email>pascal.bilbault@chru-strasbourg.fr</email>
    </contact>
    <contact_backup>
      <last_name>Pierre PERESSON</last_name>
      <phone>33.3.06.78.82.47.22</phone>
      <email>pierre.peresson@orange.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Pascal BILBAULT, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maud GANDOIN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mihaela DANCIU, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michel BOUCON, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ruxandra Aimée COJOCARU, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Claire KAM, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service des Urgences, Centre Hospitalier Intercommunal de la Lauter</name>
      <address>
        <city>Wissembourg</city>
        <zip>67160</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Didier WINGERT, MD</last_name>
      <phone>33.3.88.54.11.38</phone>
      <email>dwingert@ch-wissembourg.fr</email>
    </contact>
    <investigator>
      <last_name>Didier WINGERT, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 16, 2013</lastchanged_date>
  <firstreceived_date>September 19, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Overdose</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
